Solutions

Single Study Multi-study Enterprise Solutions

Remarque Systems’ capabilities not only meet the ICH guidelines for risk-based monitoring, but can also help companies understand the potential impact of their trials much earlier than traditionally possible.

Single Platform:

Clinical trial software users are familiar with the term ‘single platform’, which often indicates re-configuring massive amounts of data into a centralized system. Remarque Systems platform aggregates any and all data in its current format, allowing it to easily manage legacy data as well as adapting to incorporating new data.

Fast Integration:

Data integration is complete within weeks, and continuous machine learning improves insights as more data is incorporated.

Insight:

With data analytics of key risk indicators, Remarque’s platform facilitates close observation of patients in real time, across multiple populations and sites.

Inherently Dynamic:

With the flexibility to integrate any data, Remarque’s platform allows analysis and monitoring to be customized to any trial regardless of size.

What customers are saying:

We set up a FLD to notify us when a site was reaching 8 subjects within a certain age group, as study is age stratified, and we were able to identify an age group that needed to be closed down.

We noticed a trend within a site of not meeting a 24 hour dosing requirement and the site had to be retrained. This affected 4 subjects that had been enrolled and listed as completed, that had to then be listed as early terms.

We noticed a trend within a site of subjects meeting the stop dosing criteria, but dosing continued. This affected 2 subjects that had been enrolled and listed as completed, that had to then be listed as early terms.